Ligand Pharmaceuticals Inc - Company Profile
Powered by 
All the data and insights you need on Ligand Pharmaceuticals Inc in one report.
$295
- Save hours of research time and resources with
our up-to-date Ligand Pharmaceuticals Inc Strategy Report
- Understand Ligand Pharmaceuticals Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
View up-to-date information on Ligand Pharmaceuticals Inc’s latest deals, number of deals and deal values, alongside insights into its key mergers and acquisitions.
Number of Deals
Deal Value ($M)
Latest Deals
| Announced Date | Headline | Deal Type | Acquirers/Investors/Surviving Entity | Issuer/Partner/Target |
|---|---|---|---|---|
| 14 Sep 2022 | Vernalis Research and Contera Pharma Enter into Drug Discovery Agreement | Partnership | - |
Contera AS
Vernalis R&D Ltd
|
| 05 Sep 2022 | Vernalis Research and Unison Medicines Enter into Research Collaboration | Partnership | - |
Unison Medicines Inc
Vernalis R&D Ltd
|
| 23 Mar 2022 | Ligand Pharma to Merge with Avista Public Acquisition | Merger | - |
Ligand Pharmaceuticals Inc
Avista Public Acquisition II Corp
|
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
Contact the team or request a demo to find out how our data can drive your business forward
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer